These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 20160125

  • 1. Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan.
    Looyenga BD, Wiater E, Vale W, Hammer GD.
    Mol Endocrinol; 2010 Mar; 24(3):608-20. PubMed ID: 20160125
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.
    Farnworth PG, Wang Y, Escalona R, Leembruggen P, Ooi GT, Findlay JK.
    Endocrinology; 2007 Nov; 148(11):5355-68. PubMed ID: 17656464
    [Abstract] [Full Text] [Related]

  • 4. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
    Hofland J, Timmerman MA, de Herder WW, van Schaik RH, de Krijger RR, de Jong FH.
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):792-9. PubMed ID: 17121532
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors.
    Chapman SC, Bernard DJ, Jelen J, Woodruff TK.
    Mol Cell Endocrinol; 2002 Oct 31; 196(1-2):79-93. PubMed ID: 12385827
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
    Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W.
    Nature; 2000 Mar 23; 404(6776):411-4. PubMed ID: 10746731
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of betaglycan, an inhibin coreceptor, in normal human ovaries and ovarian sex cord-stromal tumors and its regulation in cultured human granulosa-luteal cells.
    Liu J, Kuulasmaa T, Kosma VM, Bützow R, Vänttinen T, Hydén-Granskog C, Voutilainen R.
    J Clin Endocrinol Metab; 2003 Oct 23; 88(10):5002-8. PubMed ID: 14557487
    [Abstract] [Full Text] [Related]

  • 11. Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis.
    Vänttinen T, Liu J, Kuulasmaa T, Kivinen P, Voutilainen R.
    J Endocrinol; 2003 Sep 23; 178(3):479-89. PubMed ID: 12967339
    [Abstract] [Full Text] [Related]

  • 12. Betaglycan localization in the female rat pituitary: implications for the regulation of follicle-stimulating hormone by inhibin.
    Chapman SC, Woodruff TK.
    Endocrinology; 2003 Dec 23; 144(12):5640-9. PubMed ID: 14500575
    [Abstract] [Full Text] [Related]

  • 13. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
    Farnworth PG, Wang Y, Leembruggen P, Ooi GT, Harrison C, Robertson DM, Findlay JK.
    J Endocrinol; 2006 Mar 23; 188(3):451-65. PubMed ID: 16522726
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A Tale of Two Proteins: Betaglycan, IGSF1, and the Continuing Search for the Inhibin B Receptor.
    Bernard DJ, Smith CL, Brûlé E.
    Trends Endocrinol Metab; 2020 Jan 23; 31(1):37-45. PubMed ID: 31648935
    [Abstract] [Full Text] [Related]

  • 16. Inhibin is an antagonist of bone morphogenetic protein signaling.
    Wiater E, Vale W.
    J Biol Chem; 2003 Mar 07; 278(10):7934-41. PubMed ID: 12493742
    [Abstract] [Full Text] [Related]

  • 17. Molecular biology of inhibin action.
    Cook RW, Thompson TB, Jardetzky TS, Woodruff TK.
    Semin Reprod Med; 2004 Aug 07; 22(3):269-76. PubMed ID: 15319829
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reducing betaglycan expression by RNA interference (RNAi) attenuates inhibin bioactivity in LbetaT2 gonadotropes.
    Escalona RM, Stenvers KL, Farnworth PG, Findlay JK, Ooi GT.
    Mol Cell Endocrinol; 2009 Aug 13; 307(1-2):149-56. PubMed ID: 19524135
    [Abstract] [Full Text] [Related]

  • 20. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle.
    Lovell TM, Knight PG, Gladwell RT.
    J Endocrinol; 2005 Sep 13; 186(3):447-55. PubMed ID: 16135664
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.